Presbyopia Progression From the Age of 40 to 79 Years in Glaucoma Patients Treated With Prostaglandin F Receptor Agonists
Between ages 40 and 79 years, glaucoma patients treated with prostaglandin F receptor agonists had higher near add power than controls. This knowledge could contribute to informing better management of glaucoma patients with presbyopia.
Authors
- Masahiko Ayaki (ORCID: https://orcid.org/0000-0002-9481-0164)
- Akiko Hanyuda (ORCID: https://orcid.org/0000-0002-2342-9550)
- Kazuno Negishi
Institutions
- Keio University (JP)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1167/tvst.14.5.25
- Citations
- 2
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.41